Jeffrey Davis

IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial

Lindsay Ackerman, Gerard Acloque, Sandro Bacchelli et al. · Nature Medicine · 2023 · 98 citations · Full text

Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan

Mikhail G. Dozmorov, Joseph Azzarello, Jonathan D. Wren et al. · BMC Cancer · 2010 · 64 citations · Full text

Evaluation of the Effect of Multiple Doses of Lansoprazole on the Pharmacokinetics and Safety of Ponatinib in Healthy Subjects

Narayana I. Narasimhan, David J. Dorer, Jeffrey Davis et al. · Clinical Drug Investigation · 2014 · 17 citations

Drug Safety, Healthy Subjects, Pharmacological Study +6

Evaluation of the effect of multiple doses of rifampin on the pharmacokinetics and safety of ponatinib in healthy subjects

Narayana I. Narasimhan, David J. Dorer, Jeffrey Davis et al. · Clinical Pharmacology in Drug Development · 2015 · 16 citations

Healthy Subjects, Immunology, Pharmacotherapy +18

Stellate ganglion block used to treat reversible cerebral vasoconstriction syndrome

Jeffrey Davis, Mehmet S. Ozcan, Jay K Kamdar et al. · Regional Anesthesia & Pain Medicine · 2021 · 13 citations